Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering
June 28, 2024 11:32 ET
|
Bluejay Diagnostics, Inc.
ACTON, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony...
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering
June 27, 2024 08:58 ET
|
Bluejay Diagnostics, Inc.
ACTON, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony...
SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
June 26, 2024 08:00 ET
|
Bluejay Diagnostics, Inc.
ACTON, Mass., June 26, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), today announced results from the primary analysis of SYMON-I, a multicenter pilot clinical study...
Bluejay Diagnostics Announces Reverse Stock Split
June 17, 2024 08:00 ET
|
Bluejay Diagnostics, Inc.
ACTON, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony...
Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
August 25, 2023 08:00 ET
|
Bluejay Diagnostics, Inc.
ACTON, Mass., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony...
Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results
August 16, 2023 07:00 ET
|
Bluejay Diagnostics, Inc.
ACTON, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony...
Bluejay Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement
August 10, 2023 16:05 ET
|
Bluejay Diagnostics, Inc.
ACTON, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony...
Bluejay Diagnostics Announces Reverse Stock Split
July 21, 2023 07:00 ET
|
Bluejay Diagnostics, Inc.
ACTON, Mass., July 21, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony...
Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy
May 19, 2023 07:00 ET
|
Bluejay Diagnostics, Inc.
ACTON, Mass., May 19, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony...
Bluejay Diagnostics Reports First Quarter 2023 Financial Results
May 10, 2023 07:30 ET
|
Bluejay Diagnostics, Inc.
ACTON, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid tests using whole blood on its...